SHELDON STEPHEN (Chief Financial Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/22/2023ACC: 0001062993-23-021357
Officer· Chief Financial Officer
Since Aug 2022
-971.00
Net shares
Net seller
$1.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
971.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−971.00
Price / share
$1.75
Trade value
$1.70K
% of position
6.6%
11/20/2023
14.71K→13.74K
Total
Net shares
−971.00
Net value
-$1.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | F · Tax Withholding | −971.00 | $1.75 | $1.70K | 6.6% | 14.71K | 13.74K |
| Total | −971.00 | -$1.70K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.11K
Total
1.11K indirect1.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.11K | Indirect |
| Total | 1.11K | 1.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported